We provide the world’s first virus removal filter paper that combines high level of biosafety with unparalleled cost-efficiency so that the biopharmaceutical industry can develop and manufacture groundbreaking therapies both faster and with fewer resources.

High prices of biologics and chronic nature of diseases combine into a heavy burden for the healthcare system. Ensuring safety of biologics against viruses is the most expensive task in bioprocessing. Our mission is to facilitate the development and industrial manufacturing of emerging biologic drugs and their generic analogues (biosimilars) in order to make these expensive products more accessible to patients.